Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,742 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,816 of 2,102 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
2,844 total, page 48 of 57
A Phase I Study of iPS Cell Generation From Patients With COPD
NCT01860898
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy
NCT00949949
EUS Guided Celiac Neurolysis
NCT01615653
Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)
NCT01253408
Varenicline and Bupropion for Smoking Cessation
NCT00935818
Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)
NCT01222182
Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects
NCT00976443
Biomarkers for Human Heart Failure
NCT03905252
Identifying Factors Underlying the Discontinuation of Triptans
NCT00890357
Registry for Study of Coils in Intracranial Aneurysms
NCT01000675
The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics
NCT00951899
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
NCT00955149
Serum Procalcitonin
NCT00954551
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT00935792
The Effects of Decreasing the Lasix Dose on the Cardiorenal System
NCT00982423
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
NCT00938457
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
NCT00937768
Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation
NCT00951301
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
NCT00918333
Greater Occipital Nerve Block for Migraine Prophylaxis
NCT00915473
Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
NCT00943176
Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
NCT00934999
Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women
NCT01186796
A Pilot Study of Renal Hypothermia During Partial Nephrectomy
NCT00888641
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis
NCT00961948
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
NCT01027767
Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians
NCT00949611
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
NCT00873366
Pentoxifylline Treatment of Acute Pancreatitis
NCT01292005
Fiber Formula Study Among Radiation Oncology Patients
NCT00888147
An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
NCT00904826
Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in Obese Adolescents
NCT00858247
Cheno Effect on Transit in Health and IBS-C
NCT00912301
Stellate Ganglion Nerve Block in Treating Women With Hot Flashes
NCT00879164
HISTOACRYL: A Study of Its Efficacy in Final Scar Formation
NCT00890578
Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
NCT01925170
Confocal Endomicroscopy for Biliary Strictures -Phase I
NCT00892632
Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery
NCT01839812
Evaluation of Radiculitis Following Use of Bone Morphogenetic Protein-2 for Interbody Arthrodesis in Spinal Surgery
NCT00984672
Wiser Choices in Acute Myocardial Infarction
NCT00888537
Lung Injury Prediction Study
NCT00889772
Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT00816595
Varenicline for the Treatment of Smokeless Tobacco
NCT00813917
Hemin in Healthy Subjects
NCT00882804
Intestinal Wall Remodeling (Infliximab Therapy) in Crohn's Disease Patients Undergoing Serial Computed Tomography (CT) Enterography
NCT00819663
The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
NCT01023802
Lp-PLA2 and Coronary Atherosclerosis in Humans
NCT01557088
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
NCT00498368
A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After Transplantation
NCT01074203
B-type Natriuretic Peptide (BNP) in Human Hypertension
NCT00953472
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Mayo Clinic: open-pipeline peers nationwide
Peers matched on 2,844 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Mayo Clinic sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 2,844 trials (± recruiting share)
- M.D. Anderson Cancer Center · 2,692 trials · 20% recruiting
- National Cancer Institute (NCI) · 3,257 trials · 10% recruiting
- Massachusetts General Hospital · 2,032 trials · 17% recruiting
- National Institute of Allergy and Infectious Diseases (NIAID) · 2,006 trials · 8% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of South Carolina · 19% recruiting · 157 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
- MemorialCare Health System · 19% recruiting · 21 trials
- University of North Texas Health Science Center · 19% recruiting · 21 trials
Related
What to do with this Mayo Clinic page
2,844 registered trials is a research-attention snapshot, not an endorsement of Mayo Clinic or any single study.
- 544 of Mayo Clinic's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition Mayo Clinic studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mayo Clinic pipeline card: 2,844 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.